LionBird

About

Portfolio

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is LionBird's primary investment focus?

LionBird is a venture capital firm that primarily invests in pre-scale digital health companies. The firm is currently investing out of its third fund, LionBird III, which is exclusively focused on early-stage digital health.

Where does LionBird operate geographically?

LionBird has operations in Tel Aviv, Israel, and the U.S., with an office in Evanston, Illinois.

How many founding teams has LionBird invested in since its inception?

Since its inception, LionBird has invested in more than 30 founding teams across the U.S. and Israel.

What was a significant recent fund closing for LionBird?

LionBird closed an $85 million digital health-focused fund in April 2022. Bahrain's Al Waha also invested in this fund in June 2022.

Can you name some of LionBird's notable portfolio companies?

According to startupim data, LionBird's portfolio includes companies like TytoCare and FundGuard. For a full list, users should refer to startupim.

What are some of LionBird's recent investment activities?

LionBird has made recent investments in companies such as Jimini Health ($17 million in March 2026) and PhaseV ($50 million in May 2025).

Has LionBird had any notable exits?

Yes, LionBird has had several exits. For example, C2i Genomics was acquired by Veracyte in January 2024 for $95 million, and PhysiMax Technologies was acquired by DarioHealth in January 2022 for $6 million.

When was LionBird founded?

LionBird was founded in 2012.

What is LionBird's investment stage focus?

LionBird invests across various stages, including Pre-Seed, Seed, A Round, and B Round.